Ibogaine, a noncompetitive inhibitor of serotonin transport, acts by stabilizing the cytoplasm-facing state of the transporter.
about
Effect of Iboga alkaloids on µ-opioid receptor-coupled G protein activationMonoamine transporters: insights from molecular dynamics simulationsDefining the blanks--pharmacochaperoning of SLC6 transporters and ABC transportersBehavioral, biological, and chemical perspectives on atypical agents targeting the dopamine transporterNonclassical pharmacology of the dopamine transporter: atypical inhibitors, allosteric modulators, and partial substratesX-ray structures of LeuT in substrate-free outward-open and apo inward-open statesLigand induced conformational changes of the human serotonin transporter revealed by molecular dynamics simulationsLigand effects on cross-linking support a conformational mechanism for serotonin transport.The N terminus of monoamine transporters is a lever required for the action of amphetaminesUnbiased simulations reveal the inward-facing conformation of the human serotonin transporter and Na(+) ion release.The high-affinity binding site for tricyclic antidepressants resides in the outer vestibule of the serotonin transporter.Cytoplasmic permeation pathway of neurotransmitter transporters.The mechanistic basis for noncompetitive ibogaine inhibition of serotonin and dopamine transportersInteraction of cocaine-, benztropine-, and GBR12909-like compounds with wild-type and mutant human dopamine transporters: molecular features that differentially determine antagonist-binding properties.The rocking bundle: a mechanism for ion-coupled solute flux by symmetrical transporters.Probing binding pocket of serotonin transporter by single molecular force spectroscopy on living cells.Unifying concept of serotonin transporter-associated currentsMolecular mechanism of serotonin transporter inhibition elucidated by a new flexible docking protocol.Loop diuretic and ion-binding residues revealed by scanning mutagenesis of transmembrane helix 3 (TM3) of Na-K-Cl cotransporter (NKCC1)Binding Mode Selection Determines the Action of Ecstasy Homologs at Monoamine TransportersTwo Na+ Sites Control Conformational Change in a Neurotransmitter Transporter HomologMechanism for alternating access in neurotransmitter transporters.Thermostabilisation of the serotonin transporter in a cocaine-bound conformation.Control of serotonin transporter phosphorylation by conformational state.Inside job: ligand-receptor pharmacology beneath the plasma membrane.Emulating proton-induced conformational changes in the vesicular monoamine transporter VMAT2 by mutagenesis.Structural perspectives on secondary active transporters.Conformational dynamics of a neurotransmitter:sodium symporter in a lipid bilayer.Pharmacological Chaperones of the Dopamine Transporter Rescue Dopamine Transporter Deficiency Syndrome Mutations in Heterologous Cells.Dopamine transport by the serotonin transporter: a mechanistically distinct mode of substrate translocation.Biophysical Approaches to the Study of LeuT, a Prokaryotic Homolog of Neurotransmitter Sodium Symporters.Importance of the Extracellular Loop 4 in the Human Serotonin Transporter for Inhibitor Binding and Substrate Translocation.Mutations in the carboxyl-terminal SEC24 binding motif of the serotonin transporter impair folding of the transporter.Fluoxetine (Prozac) binding to serotonin transporter is modulated by chloride and conformational changes.Functional Rescue of a Misfolded Drosophila melanogaster Dopamine Transporter Mutant Associated with a Sleepless Phenotype by Pharmacological Chaperones.Conformational state interactions provide clues to the pharmacochaperone potential of serotonin transporter partial substrates.The N Terminus Specifies the Switch between Transport Modes of the Human Serotonin Transporter.A salt bridge linking the first intracellular loop with the C terminus facilitates the folding of the serotonin transporter.Dual Action of Zn2+ on the Transport Cycle of the Dopamine Transporter.A cytosolic relay of heat shock proteins HSP70-1A and HSP90β monitors the folding trajectory of the serotonin transporter.
P2860
Q21132475-E8149B4A-5940-4AEC-93D8-42BF1F96D5C2Q26777242-1983238A-06DD-481D-A04A-4697F072DE85Q26825537-A134972B-649F-4F37-A906-F8022858851DQ26829749-D7444109-1AF2-4E4D-9DB5-B536BFC59645Q26853319-35847553-B2A1-499C-A536-B1E7DD1A2FEAQ27676655-F6F0A7C8-7B76-444F-9E7C-6D0D7988DF7AQ28533835-149F5E6D-DCAF-4204-AC71-F008B1E9A973Q33553309-D2EDC4F9-1D71-4059-AEAC-E6DE95E5C17AQ33796294-4D5C99B4-F8A8-499A-9E39-D3B5E2F349FFQ34064167-D5DA0B15-8FE6-4078-B9FB-4313CB4D7C23Q34137102-733FD210-F0DF-4ADE-BEE5-39F0A0C8CF87Q34202128-27024C2B-9088-4CE5-871F-FF938D6DFEECQ34660686-45815F01-3276-4554-B113-AF906A044EE8Q34825605-AE97B64C-F3A6-4E71-933F-6D4A3965CE4AQ35016767-8145FD5F-1936-4DB1-97F5-691D3529A22CQ35643579-73C14347-B545-44A2-BE29-55C9FBFC6222Q35643721-16538667-7B07-4A18-BF36-FA2156945EF6Q35975646-1A9CCCF2-77D8-4AAC-9906-BD59B5D5E976Q36006806-7B6525C5-E78C-44A6-BDCA-ABBF078E70DAQ36432395-18B7578B-188F-4987-96A1-05AB5C634FFFQ36466214-A3DC2AB3-5907-4AEB-A850-F5BC10F555DFQ36785076-2CEE38B8-996C-4594-AB8C-DF187765F7FBQ36917238-9B401F0B-69FF-4FA4-971E-DF585BB3C490Q36930972-CD7B5367-185F-4499-AD28-2BDC5F30EC7CQ36989788-C5A49981-12C6-42A9-8D40-3C39AFEEE0FBQ37451183-685926F4-1D6A-4B7F-9561-63074390D242Q37775229-40B70D15-4239-4A4D-8937-B9652F19BB19Q38949208-7CAF4270-DC0B-44C9-9461-96FAE7DFCDEAQ39459667-E12EB869-D98A-4CFD-8449-3E0474EF98E0Q39551874-27535836-7462-42FE-BE17-8C44902BA44BQ39809302-967C770A-037C-4E71-817C-9A9A36633E02Q41027994-CD3219FA-63DD-440F-88D6-7503D9DBEEA3Q41175275-0FDE0E65-EAD1-4FC0-82FD-5083AF25206FQ41536585-ADC160E9-7DE5-47C2-AB13-ABE9603477FAQ41549350-2E195DFB-3CAA-45B4-9F9D-9846B052545DQ41861390-DAC3786E-AA87-4347-A249-303FDC73AEA1Q41970582-EB904F6C-8D87-48AF-B755-6320F68822D3Q42133017-A34E9216-3639-46FD-A727-32E6F1B3F5ECQ42249280-412029E0-7AC4-48DA-93E7-60A5FEF52CABQ42272217-09CD7EFF-50DD-486C-958C-7B3CDF1F94F8
P2860
Ibogaine, a noncompetitive inhibitor of serotonin transport, acts by stabilizing the cytoplasm-facing state of the transporter.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Ibogaine, a noncompetitive inh ...... cing state of the transporter.
@en
Ibogaine, a noncompetitive inh ...... cing state of the transporter.
@nl
type
label
Ibogaine, a noncompetitive inh ...... cing state of the transporter.
@en
Ibogaine, a noncompetitive inh ...... cing state of the transporter.
@nl
prefLabel
Ibogaine, a noncompetitive inh ...... cing state of the transporter.
@en
Ibogaine, a noncompetitive inh ...... cing state of the transporter.
@nl
P2093
P2860
P356
P1476
Ibogaine, a noncompetitive inh ...... cing state of the transporter.
@en
P2093
Gary Rudnick
Miriam T Jacobs
Scott D Campbell
Yuan-Wei Zhang
P2860
P304
29441-29447
P356
10.1074/JBC.M704456200
P407
P577
2007-08-13T00:00:00Z